BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15466267)

  • 1. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.
    Sun DF; Zheng Z; Tummala P; Oh J; Schaefer F; Rabkin R
    J Am Soc Nephrol; 2004 Oct; 15(10):2630-6. PubMed ID: 15466267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia.
    Schaefer F; Chen Y; Tsao T; Nouri P; Rabkin R
    J Clin Invest; 2001 Aug; 108(3):467-75. PubMed ID: 11489940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
    Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
    J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resistance to growth hormone in uremia.
    Zheng Z; Sun DF; Tummala P; Rabkin R
    Kidney Int; 2005 Mar; 67(3):858-66. PubMed ID: 15698425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
    Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
    Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
    Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
    Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
    Chen Y; Sun D; Krishnamurthy VM; Rabkin R
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.
    Miquet JG; Sotelo AI; Bartke A; Turyn D
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E600-7. PubMed ID: 15899943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
    Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
    Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ames dwarf (Prop1(df)/Prop1(df)) mice display increased sensitivity of the major GH-signaling pathways in liver and skeletal muscle.
    Miquet JG; Muñoz MC; Giani JF; González L; Dominici FP; Bartke A; Turyn D; Sotelo AI
    Growth Horm IGF Res; 2010 Apr; 20(2):118-26. PubMed ID: 20022531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance.
    Miquet JG; Sotelo AI; Dominici FP; Bonkowski MS; Bartke A; Turyn D
    J Endocrinol; 2005 Dec; 187(3):387-97. PubMed ID: 16423818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
    Morales O; Lindgren U; Haldosén LA
    J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.
    Sotelo AI; Miquet JG; González L; Bartke A; Turyn D
    Growth Horm IGF Res; 2008 Apr; 18(2):148-56. PubMed ID: 17881271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling.
    Johansen T; Laurino C; Barreca A; Malmlöf K
    Growth Horm IGF Res; 2005 Feb; 15(1):55-63. PubMed ID: 15701573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherent growth hormone resistance in the skeletal muscle of the fine flounder is modulated by nutritional status and is characterized by high contents of truncated GHR, impairment in the JAK2/STAT5 signaling pathway, and low IGF-I expression.
    Fuentes EN; Einarsdottir IE; Valdes JA; Alvarez M; Molina A; Björnsson BT
    Endocrinology; 2012 Jan; 153(1):283-94. PubMed ID: 22028448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication: A milk trait-associated polymorphism in the bovine growth hormone receptor gene does not affect receptor signaling.
    Zhou Y; Jiang H
    J Dairy Sci; 2006 May; 89(5):1761-4. PubMed ID: 16606747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
    Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
    Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin-induced growth hormone resistance in skeletal muscle.
    Chen Y; Sood S; Krishnamurthy VM; Rotwein P; Rabkin R
    Endocrinology; 2009 Aug; 150(8):3620-6. PubMed ID: 19443577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.